Testicular non-seminomatous germ cell tumor
MONDO:0006447A testicular germ cell tumor characterized by the absence of a seminomatous component. It includes embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, and mixed forms.
Also known as: non-dysgerminomatous germ cell tumor of testis, non-dysgerminomatous germ cell tumour of testis, non-seminomatous germ cell tumor of testis, non-seminomatous germ cell tumour of testis, testicular germ cell tumor non-seminomatous, testicular germ cell tumour non-seminomatous, testicular non seminomatous germ cell tumor, testicular non seminomatous germ cell tumour
1445 clinical trials for this condition and its sub-types, 7 tagged with Testicular non-seminomatous germ cell tumor itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Testicular non-seminomatous germ cell tumor
-
Testicular non-seminomatous germ cell cancer 3 trials · 4 incl. sub-types
3 sub-types
- Testicular embryonal carcinoma 1 trial · 2 incl. sub-types Sub-types →
- Choriocarcinoma of testis 1 trial Sub-types →
- Testicular yolk sac tumor 1 trial Sub-types →
-
Testicular trophoblastic tumor 0 trials · 1 incl. sub-types
1 sub-type
- Choriocarcinoma of testis 1 trial Sub-types →
Most studied deeper sub-types
-
Experimental CAR T-Cell therapy targets rare testicular cancer
Disease control CompletedThis phase 2 study tested a new treatment for nonseminomatous germ cell tumors (a type of testicular cancer) that had not responded to standard therapy. The treatment used the patient's own immune cells (T cells) that were genetically modified to recognize and attack cancer cells…
Phase 2 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New chemo drug shows promise for tough testicular cancers
Disease control CompletedThis phase 2 trial tested a chemotherapy drug called cabazitaxel in 34 men with advanced testicular cancer that had already been treated with at least two other chemotherapies. The goal was to see if cabazitaxel could shrink tumors, including those that spread to the brain. Cabaz…
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC